Latest Industry Insights

This Q&A with researchers from the Buck Institute and Nautilus Biotechnology reveals how single-molecule proteomics enables unprecedented mapping of tau proteoforms across Alzheimer’s-relevant brain regions.

In this interview, Petra Gerhards discusses the challenges of detecting TFA in wine and how advances in technology are enabling more reliable and sensitive monitoring.

In this interview, Dr. Robert Beal discusses how advances in digital polymerase chain reaction technologies are reshaping research workflows.

By harnessing advances in imaging technology and precision medicine, Serenatis Bio is hoping to transform the landscape of OCD treatments by targeting the root neurological causes of the disorder.

Discover how an AI-enabled electronic lab notebook can help researchers to optimize experiments, collaborate and work smarter in R&D labs.

At the recent ELRIG Drug Discovery conference, Technology Networks spoke with Dr. Kundan Sharma to learn more about how cell-free expression platforms are transforming membrane protein research.

In a year defined by volatility and rapid transformation, the latest Horizons Report from CRB Group offers a revealing look at how life sciences organizations are navigating uncertainty while maintaining cautious optimism.

Discover how cell-free DNA synthesis can accelerate mRNA vaccines and therapies, enhancing production efficiency and lowering contamination risks.

Discover how explorations into the 3D structure of the genome and innovative multiomics platform technology are reshaping the future of precision medicine.

Technology Networks recently spoke with Santhosh Nair to learn more about polyautoimmunity and the evolving role of clinical laboratories in its detection and management.